|
|
ROLES OF MLL4-COMPLEX IN DEVELOPMENT OF HYPOTHALAMIC ARCUATE NEURONS |
| 1R56DK118912-01A1 |
LEE, JAE W |
NIDDK |
2019 |
|
|
RANDOMIZED ESRD TRIAL COMPARING CBT ALONE VERSUS WITH BUPRENORPHINE (RECOVER) |
| 1U01DK123786-01 |
MEHROTRA, RAJNISH |
NIDDK |
2019 |
|
|
UNIVERSITY OF ILLINOIS AT CHICAGO HEMODIALYSIS OPIOID PRESCRIPTION EFFORT (HOPE) CLINICAL CENTER |
| 1U01DK123787-01 |
FISCHER, MICHAEL J. |
NIDDK |
2019 |
|
|
PAIN REDUCTION AND OPIOID MEDICATION SAFETY IN ESRD (PROMISE) STUDY |
| 1U01DK123812-01 |
JHAMB, MANISHA |
NIDDK |
2019 |
|
|
UPENN SCIENTIFIC AND DATA RESEARCH CENTER FOR THE HOPE CONSORTIUM TO REDUCE PAIN AND OPIOID USE IN HEMODIALYSIS |
| 1U01DK123813-01 |
DEMBER, LAURA M |
NIDDK |
2019 |
|
|
PAIN, OPIOIDS, AND ESRD RISK REDUCTION WITH MINDFULNESS AND BUPRENORPHINE (POEM-B): A 3-ARM MULTI-SITE RANDOMIZED TRIAL IN HEMODIALYSIS PATIENTS |
| 1U01DK123814-01 |
CHARYTAN, DAVID M |
NIDDK |
2019 |
|
|
THE HEMODIALYSIS OPIOID PRESCRIPTION EFFORT CONSORTIUM |
| 1U01DK123816-01 |
JOHANSEN, KIRSTEN L. |
NIDDK |
2019 |
|
|
VIDEO-TELECARE COLLABORATIVE PAIN MANAGEMENT TO IMPROVE FUNCTION AND REDUCE OPIOID RISK IN PATIENTS WITH END STAGE RENAL DISEASE RECEIVING HEMODIALYSIS |
| 1U01DK123817-01 |
BECKER, WILLIAM C |
NIDDK |
2019 |
|
|
REDUCING CHRONIC PAIN AND OPIOID USE IN HEMODIALYSIS PATIENTS |
| 1U01DK123818-01 |
KALIM, SAHIR |
NIDDK |
2019 |
|
|
VANDERBILT-WEST VIRGINIA (VWV) COLLABORATIVE: A HOPE CONSORTIUM CLINICAL CENTER |
| 1U01DK123821-01 |
CAVANAUGH, KERRI |
NIDDK |
2019 |
